Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Trupanion Launches Signature Medical Insurance Product in Europe
-
Banijay Group: Weekly share transactions
-
Solvay: acquisition of own shares
-
Boussard & Gavaudan Holding Ltd (GBP): Newsletter August 2024
-
Boussard & Gavaudan Holding Ltd (EUR): Newsletter August 2024
-
Ranger Investments' Devin Holland, Partner and Senior Analyst, Named a P&I Influential Women in Institutional Investing Rising Star
-
Ziebart Launches National Branding Campaign Featuring Knight in Shining Armor
-
Blood Donations Are Needed for Those Battling Cancer
-
GreenEnergyBreaks — Lucid Group Inc. (NASDAQ: LCID) Announces New Software Update for Lucid Air
-
Battelle Awarded U.S. Department of Defense Contract to Develop an Improved Nerve Agent Countermeasure
-
D2E Labs Acquires Lunge Marketing, Expanding Global Marketplace Services
-
Monumental Sports & Entertainment and TikTok Announce Partnership
-
Crisis Text Line “You Good?” Campaign Empowers Connection During Suicide Prevention Month and World Mental Health Day
-
Heilind Electronics Introduces Brady M410 and M510 Series Printers
-
‘Wood-Boat Mecca’ Carries on a Time-Honored Nautical Tradition
-
Templeton Emerging Markets Income Fund (“TEI” or the “Fund”) Announces Distribution
-
Franklin Universal Trust (“FT” or the “Fund”) Announces Distribution
-
Eurofins: Purchases of Own Shares From September 02nd to September 06th, 2024
-
Sopra Steria: Weekly Disclosure of Transactions in Own Shares From September 2nd to September 6th, 2024
-
Jio Expands Video Content Security Relationship with Verimatrix
-
Carmila: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règleme
-
California Credit Union Honored With 2024 Social Impact Award From California and Nevada Credit Union Leagues
-
Euronext announces volumes for August 2024
-
Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
-
Syensqo - Acquisition of own shares
-
Bouygues: Disclosure of trading in own shares
-
Fujairah Mountain Shooting Championship Returns for a New Edition in February 2025
-
Franklin Limited Duration Income Trust (“FTF” or the “Fund”) Announces Distribution
-
LECTRA: Monthly declaration of the total number of shares and voting rights composing the company's capital (at August 31th, 2024)
-
Greystone Closes $56.3 Million in Combined Freddie Mac Financing and Preferred Equity to Refinance North Carolina Multifamily Property
-
Three College-Bound Students Awarded Healthfirst Education & Leadership Program Scholarships
-
Valsoft Enters the Document Flow Automation Space with the Acquisition of ACOM Software
-
Boehringer's zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
-
Nexion Travel Group Survey Shows Selling Travel can be Fulfilling, Lucrative Career
-
Rémy Cointreau: Information on the Total Number of Voting Rights and Shares Forming the Share Capital
-
Market of Choice Celebrates its 45th Anniversary with the Return of the Product Experience Show
-
HILL'S PET NUTRITION AND SHELTER PARTNERS HELP PET PARENTS PREPARE FOR EMERGENCIES
-
ATTENTION NASDAQ: SMCI INVESTORS: Contact Berger Montague About a Super Micro Computer Class Action Lawsuit
-
Brightrock Gold Corp. Announces The Appointment of Astra Audit And Advisory LLC, A PCAOB-Registered Independent Auditor, To Support The Continued Transition To A Fully SEC-Reporting Corporation
-
Fortune Names Best MBA Programs for 2025
-
HOT OFF THE RUNWAY: BAILEYS MINIS ORIGINAL IRISH CREAM LIQUEUR MAKES ITS NEW YORK FASHION WEEK DEBUT IN PARTNERSHIP WITH 3.1 PHILLIP LIM WITH THE MOST INDULGENT ACCESSORY
-
Gaby Natale Joins Forces with Susan G. Komen® as Official Ambassador
-
CARGOTEC CORPORATION: SHARE REPURCHASE 9.9.2024
-
Share buyback programme completed
-
Weekly report share buyback from September 2 to September 6, 2024
-
Defiance ETFs Files to Increase Leverage on MSTX (MicroStrategy) ETF from 1.75x to 2x, Surpassing $100 Million in Assets
-
AIDA Cruises tests further biofuels
-
Golden Tee PGA TOUR 2025 Unleashed on North America
-
AISA Pharma Receives FDA Orphan Drug Designation for AISA-021 for Treatment of Systemic Sclerosis
-
Lake Street Capital Markets Presents BIG8 - The 8th Annual Best Ideas Growth Conference
